Navigation Links
Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit
Date:2/22/2013

NEW YORK, Feb. 22, 2013 /PRNewswire/ -- Dr Wei William Cao, PhD, BM, President of Cellular Biomedicine Group presented a keynote address at the 8th annual New York Stem Cell Summit on February 19, 2013. Dr Cao discussed the current government regulations and support of cellular medicine research and development in China.

The New York Stem Cell Summit featured more than 30 of the world's leaders in the stem cell industry, bringing the future of this dynamic industry to life for investors, industry, practitioners, and analysts. The presentations and networking provided insight into investment opportunities in the stem cell marketplace, groundbreaking stem cell products that physicians use today, and the growing market potential.

Dr Cao served as Technical Manager for Bayer Diagnostics Asia Pacific region, General Manager of GenoMultix Ltd., President of Wuxi New District Hospital, and China General Manager of Affymetrix, a world leader in genetic analysis industry. Dr Cao has extensive research experience in immunopharmacology at Harvard Medical School and Stanford Medical School.  He holds a Guest Professorship at the Department of Histology and Embryology of Fudan University Medical School, Shanghai China. Dr Cao earned a Bachelor's degree in Medicine from Fudan University Medical School, Shanghai China, and PhD degree in immunopharmacology from Medical College of Virginia, Richmond Virginia. He is an inventor of 24 patents in the field of genetic analysis and stem cell technology, especially adipose derived stem cell preparation and its disease treatment applications.

About Cellular Biomedicine Group
Cellular Biomedicine Group, Ltd. develops proprietary cell therapies for the treatment of certain degenerative diseases. Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com

Forward-Looking Statements

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements.

CONTACT:

Jeff Ramson
Investor Relations
ProActive Capital Group
646-863-6341

Sarah Kelly
Director of Corporate Communications
(+86) 21 54069990 
sarah.kelly@cellbiomedgroup.com

 



 

 

 


'/>"/>
SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cellular Biomedicine Group Announces ISO 9001:2008 Certification and ISO-14644 Cleanroom Certification
2. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
3. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
4. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
5. Proteins shine a brighter light on cellular processes
6. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
7. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
8. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
9. A 300 Million Euro Boost for Biomedicine in Berlin
10. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
11. Photonics21 Group Announces Prize for Photonics with Industrial Impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , ... January 11, 2017 , ... ... are observed in clinical settings, it is becoming increasingly clear that the evolution ... on culture-based methods, the standard in the study of clinical resistance, has vastly ...
(Date:1/11/2017)... ... January 11, 2017 , ... IsoPlexis Corporation ... platform to measure the proteomic function of individual cells in patients, today announced ... grant from the National Institute on Aging of the National Institutes of Health ...
(Date:1/11/2017)... Collins, Colorado (PRWEB) , ... January 11, 2017 ... ... of dynamic aqueous plasma technology platforms, announced today that the National Science Foundation ... IIB supplement for $500,000. The funds will be used to commercialize the Symbios ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced Polymer Monitoring Technologies (APMT) ... Bartylla will lead European initiatives for APMT’s product lines serving polymer and biopharmaceutical ... to European manufacturers and researchers. Bernhard brings significant experience in our application areas ...
Breaking Biology Technology:
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... India , Dec. 8, 2016 Market Research Future ... Service Market. The global Mobile Biometric Security and Service Market is ... 2016 to 2022. Market Highlights: ... , , Mobile ... pace due to the increasing need of authentication and security from ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
Breaking Biology News(10 mins):